NCT07724405: Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage
- State
- Under way
- Phase
- Phase 2
- People
- 150 planned
- Started
- 10 Jul 2026
- Primary completion
- 10 Aug 2027
- Arms
- Recombinant G-CSF 130 mcg SC
- Results
- None posted
- 10 Jul 2026: Trial started
- 24 Jul 2026: Trial registered